A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)

NCT02584543 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

602

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis E
Hepatitis B

Interventions

BIOLOGICAL: HEV vaccine
BIOLOGICAL: HBV vaccine

Sponsor

Xiamen Innovax Biotech Co., Ltd